CMS announced an increase in Medicare payment for at-home administration of COVID-19 vaccines. Medicare will now pay $75 per at-home dose, nearly double its previous $40 adminitration rate.Read More »
CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.Read More »
NAHRI supports the professional accomplishments of all its members and the revenue integrity community at large. If you know a revenue integrity professional who has gone above and beyond in their role—be it a promotion, great idea, or helping hand—we want to help you give them a shout out.Read More »
Jugna J. Shah, MPH, CHRI, discusses why innovative therapies and technologies call for innovations in existing coding, billing, and reimbursement models.Read More »
Ronald Hirsch, MD, FACP, CHCQM, CHRI, examines recent changes to commercial payer prior authorization requirements and how it affects revenue integrity.Read More »
Q: What impact has the COVID-19 public health emergency had on your chargemaster approval process? How did you adapt to chargemaster changes?Read More »
